Aperio Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $697K | Sell |
27,707
-8,257
| -23% | -$208K | ﹤0.01% | 1796 |
|
|
2020
Q3 | $750K | Buy |
35,964
+6,578
| +22% | +$137K | ﹤0.01% | 1590 |
|
|
2020
Q2 | $698K | Buy |
29,386
+2,710
| +10% | +$64.4K | ﹤0.01% | 1594 |
|
|
2020
Q1 | $480K | Buy |
26,676
+8,869
| +50% | +$160K | ﹤0.01% | 1670 |
|
|
2019
Q4 | $422K | Buy |
17,807
+1,906
| +12% | +$45.2K | ﹤0.01% | 1895 |
|
|
2019
Q3 | $437K | Buy |
15,901
+2,344
| +17% | +$64.4K | ﹤0.01% | 1833 |
|
|
2019
Q2 | $449K | Sell |
13,557
-4,874
| -26% | -$161K | ﹤0.01% | 1845 |
|
|
2019
Q1 | $646K | Buy |
18,431
+1,392
| +8% | +$48.8K | ﹤0.01% | 1597 |
|
|
2018
Q4 | $566K | Sell |
17,039
-120
| -0.7% | -$3.99K | ﹤0.01% | 1606 |
|
|
2018
Q3 | $864K | Sell |
17,159
-572
| -3% | -$28.8K | ﹤0.01% | 1486 |
|
|
2018
Q2 | $1.06M | Buy |
17,731
+2,948
| +20% | +$176K | 0.01% | 1348 |
|
|
2018
Q1 | $677K | Buy |
14,783
+2,104
| +17% | +$96.4K | ﹤0.01% | 1545 |
|
|
2017
Q4 | $505K | Buy |
12,679
+108
| +0.9% | +$4.3K | ﹤0.01% | 1700 |
|
|
2017
Q3 | $503K | Buy |
12,571
+244
| +2% | +$9.76K | ﹤0.01% | 1656 |
|
|
2017
Q2 | $531K | Buy |
12,327
+4,441
| +56% | +$191K | ﹤0.01% | 1618 |
|
|
2017
Q1 | $247K | Buy |
+7,886
| New | +$247K | ﹤0.01% | 1923 |
|